Recognition and Control of Mtb Infected Cells:
From Basics to the Clinic

On June 13 - 14, 2023 the Working Group on New TB Vaccines (WGNV) and the National Institute for Allergy and Infectious Diseases (NIAID) co-hosted a workshop on Recognition of Mtb-Infected Cells: From Basics to the Clinic. This workshop was intended to address the need for correlates and to identify platforms that measure recognition or control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for Research and Development of New TB Vaccines and the Strategic Framework for New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.

The overall goals of this workshop were to:

  • Elucidate the mechanisms by which the immune system recognizes the Mtb-infected cell
  • Explore the degree to which such recognition can lead to control of the intracellular microbe, and
  • Discuss the translational implications of these observations

Each session of this interactive workshop started with three short presentations that provided a high-level overview of key topics within the session theme, followed by a discussion between the session chairs, speakers, and participants.

Read the meeting report, published in Frontiers in Tuberculosis

Expand the Program and Presentations section below for a detailed agenda and links to presentations, where permission was given by the speakers to publish them.

Expand the Speakers and Chairs section for information about the workshop session chairs and speakers.